Pekka Holmström
Biographic Data
| ID | 7775402 |
|---|---|
| NAME | Pekka Holmström |
| GIVEN NAMES | Pekka |
| FAMILY NAME | Holmström |
| SIGNATURE | HOLMSTRÖM P |
| AFFILIATIONS | Finnish Institute for Health and Welfare |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2007 |
| LATEST PUBLICATION YEAR | 2010 |
| H-INDEX | 0 |
Treatment outcome of extra-pulmonary tuberculosis in Finland
The proportion of favourable outcome was far below the goal set by the WHO. Age and comorbidities, playing an important role in treatment success, are not available in routine outcome data. Therefore, comparisons between countries should be made in cohort analyses incorporating data on comorbidities
Risk factors for poor tuberculosis treatment outcome in Finland
We observed a significant association with unfavourable outcome for the specialty responsible for treatment being other than pulmonary, but not for the volume of cases, which has implications for system arrangements. Poor outcomes associated with immunosuppression and advanced age, with frequent comorbidity, stress a low threshold of suspicion, availability of rapid diagnostics, and early empiric treatment as probable approaches in attempting to …
No prominent works on this page.
Risk factors for poor tuberculosis treatment outcome in Finland
We observed a significant association with unfavourable outcome for the specialty responsible for treatment being other than pulmonary, but not for the volume of cases, which has implications for system arrangements. Poor outcomes associated with immunosuppression and advanced age, with frequent comorbidity, stress a low threshold of suspicion, availability of rapid diagnostics, and early empiric treatment as probable approaches in attempting to …
Treatment outcome of extra-pulmonary tuberculosis in Finland
The proportion of favourable outcome was far below the goal set by the WHO. Age and comorbidities, playing an important role in treatment success, are not available in routine outcome data. Therefore, comparisons between countries should be made in cohort analyses incorporating data on comorbidities
Cohort (2 works) · Cohort study (2 works) · Epidemiology (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pathology (2 works) · Pneumocystis jirovecii pneumonia detection and treatment (2 works) · Pneumonia and Respiratory Infections (2 works) · Tuberculosis (2 works) · Tuberculosis Research and Epidemiology (2 works)